The GLS gene is regulated by the mediators of oncogenesis such as MYC via miR-23s [9], Rho GTPases (Cdc42, Rac1, RhoC) [10], and Notch [11], while the GLS2 gene was identified as a p53 tumor suppressor downstream target [12]. This evidence concerns the gene GLS2 and neoplasm.